Intraperitoneal cisplatin therapy in ovarian cancer: comparison with standard intravenous carboplatin and paclitaxel

MeSH terms

• Antineoplastic Agents / administration & dosage*
• Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
• Antineoplastic Combined Chemotherapy Protocols / adverse effects
• Carboplatin / administration & dosage
• Carboplatin / adverse effects
• Cisplatin / administration & dosage*
• Cisplatin / adverse effects
• Clinical Trials, Phase III as Topic
• Combined Modality Therapy
• Female
• Humans
• Infusions, Intravenous
• Infusions, Parenteral
• Neoplasm Staging
• Ovarian Neoplasms / drug therapy*
• Ovarian Neoplasms / pathology
• Ovarian Neoplasms / surgery
• Paclitaxel / administration & dosage
• Paclitaxel / adverse effects
• Randomized Controlled Trials as Topic